Distinct inflammatory and cytopathic characteristics of Escherichia coli isolates from inflammatory bowel disease patients

International Journal of Medical Microbiology

Volumn 305, Issue 8, 2015, Pages 925-936

  Jensen, Stina Rikke ^a,d   Mirsepasi Lauridsen, Hengameh Chloé ^b   Thysen, Anna Hammerich ^a   Brynskov, Jørn ^c   Krogfelt, Karen A ^b   Petersen, Andreas Munk ^c   Pedersen, Anders Elm ^c   Brix, Susanne ^a  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d NOVO NORDISK A S   (Denmark)

Author keywords

Cell death; Cytokine profile; Dendritic cells; IBD associated E. coli; Inflammation

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 23; INTERLEUKIN 6; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ARTICLE; BACTERIAL COLONIZATION; CELL DEATH; CELL STIMULATION; CELL VIABILITY; CLINICAL ARTICLE; COLON; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOPATHOGENIC EFFECT; DENDRITIC CELL; DIARRHEAGENIC ESCHERICHIA COLI; FECES; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; ILEUM; INFLAMMATORY BOWEL DISEASE; INTESTINE EPITHELIUM CELL; MONOCYTE; MONOCYTE DERIVED DENDRITIC CELL; NON DIARRHEAGENIC ESCHERICHIA COLI; NONHUMAN; PATHOGENESIS; PHENOTYPE; PREVALENCE; COCULTURE; COMPLICATION; EPITHELIUM CELL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; IMMUNOLOGY; ISOLATION AND PURIFICATION; MICROBIOLOGY; PATHOGENICITY; SECRETION (PROCESS);

CELL DEATH; COCULTURE TECHNIQUES; CYTOKINES; DENDRITIC CELLS; EPITHELIAL CELLS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; INFLAMMATORY BOWEL DISEASES; REACTIVE OXYGEN SPECIES;

EID: 84989820515     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2015.10.002     Document Type: Article

References (41)

1. Ashida H., Mimuro H., Ogawa M., Kobayashi T., Sanada T., Kim M., Sasakawa C. Cell death and infection: a double-edged sword for host and pathogen survival. J. Cell Biol. 2011, 195:931-942.
2. Barnich N., Carvalho F.A., Glasser A.L., Darcha C., Jantscheff P., Allez M., Peeters H., Bommelaer G., Desreumaux P., Colombel J.F., Darfeuille-Michaud A. CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease. J. Clin. Invest. 2007, 117:1566-1574.
3. Blom M., Meyer A., Gerner-Smidt P., Gaarslev K., Espersen F. Evaluation of Statens Serum Institut enteric medium for detection of enteric pathogens. J. Clin. Microbiol. 1999, 37:2312-2316.
4. Boudeau J., Glasser A.L., Julien S., Colombel J.F., Darfeuille-Michaud A. Inhibitory effect of probiotic Escherichia coli strain Nissle 1917 on adhesion to and invasion of intestinal epithelial cells by adherent-invasive E-coli strains isolated from patients with Crohn's disease. Aliment. Pharmacol. Ther. 2003, 18:45-56.
5. Boudeau J., Glasser A.L., Masseret E., Joly B., Darfeuille-Michaud A. Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn's disease. Infect. Immun. 1999, 67:4499-4509.
6. Clermont O., Bonacorsi S., Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 2000, 66:4555-4558.
7. Conte M.P., Schippa S., Zamboni I., Penta M., Chiarini F., Seganti L., Osborn J., Falconieri P., Borrelli O., Cucchiara S. Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease. Gut 2006, 55:1760-1767.
8. Darfeuille-Michaud A., Boudeau J., Bulois P., Neut C., Glasser A.L., Barnich N., Bringer M.A., Swidsinski A., Beaugerie L., Colombel J.F. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 2004, 127:412-421.
9. Dinarello C.A. IL-18: a T-H1-inducing, proinflammatory cytokine and new member of the IL-1 family. J. Allergy Clin. Immunol. 1999, 103:11-24.
10. Fuss I.J., Heller F., Boirivant M., Leon F., Yoshida M., Fichtner-Feigl S., Yang Z.Q., Exley M., Kitani A., Blumberg R.S., Mannon P., Strober W. Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. J. Clin. Invest. 2004, 113:1490-1497.
11. Fuss I.J., Neurath M., Boirivant M., Klein J.S., delaMotte C., Strong S.A., Fiocchi C., Strober W. Disparate CD4(+) lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease - Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J. Immunol. 1996, 157:1261-1270.
12. Glasser A.L., Boudeau G., Barnich N., Perruchot M.H., Colombel J.F., Darfeuille-Michaud A. Adherent invasive Escherichia coli strains from patients with Crohn's disease survive and replicate within macrophages without inducing host cell death. Infect. Immun. 2001, 69:5529-5537.
13. Grozdanov L., Raasch C., Schulze J., Sonnenborn U., Gottschalk G., Hacker J., Dobrindt U. Analysis of the genome structure of the nonpathogenic probiotic Escherichia coli strain Nissle 1917. J. Bacteriol. 2004, 186:5432-5441.
14. Heller F., Florian P., Bojarski C., Richter J., Christ M., Hillenbrand B., Mankertz J., Gitter A.H., Burgel N., Fromm M., Zeitz M., Fuss I., Strober W., Schulzke J.D. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology 2005, 129:550-564.
15. Huebner C., Ding Y.Y., Petermann I., Knapp C., Ferguson L.R. The probiotic Escherichia coli Nissle 1917 reduces pathogen invasion and modulates cytokine expression in Caco-2 cells infected with Crohn's disease-associated E. coli LF82. Appl. Environ. Microbiol. 2011, 77:2541-2544.
16. Jensen S.R., Fink L.N., Nielsen O.H., Brynskov J., Brix S. Ex vivo intestinal adhesion of Escherichia coli LF82 in Crohn's disease. Microb. Pathog. 2011, 51:426-431.
17. Jonkers D., Penders J., Masclee A., Pierik M. Probiotics in the management of inflammatory bowel disease a systematic review of intervention studies in adult patients. Drugs 2012, 72:803-823.
18. Kjaeldgaard P., Nissen B., Lange N., Laursen H. Evaluation of minibact, a new system for rapid identification of enterobacteriaceae - comparison of minibact, micro-Id and Api-20e with a conventional method as reference. Acta Pathol. Microbiol. Immunol. Scand. B 1986, 94:57-61.
19. Kotlowski R., Bernstein C.N., Sepehri S., Krause D.O. High prevalence of Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel disease. Gut 2007, 56:669-675.
20. Kroeger K.M., Sullivan B.M., Locksley R.M. IL-18 and IL-33 elicit Th2 cytokines from basophils via a MyD88-and p38 alpha-dependent pathway. J. Leukoc. Biol. 2009, 86:769-778.
21. Kruis W., Fric P., Pokrotnieks J., Lukas M., Fixa B., Kascak M., Kamm M.A., Weismueller J., Beglinger C., Stolte M., Wolff C., Schulze J. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 2004, 53:1617-1623.
22. Langholz E., Munkholm P., Davidsen M., Binder V. Course of ulcerative-colitis - analysis of changes in disease-activity over years. Gastroenterology 1994, 107:3-11.
23. Leach S.T., Messina I., Lemberg D.A., Novick D., Rubenstein M., Day A.S. Local and systemic interleukin-18 and interleukin-18-binding protein in children with inflammatory bowel disease. Inflamm. Bowel Dis. 2008, 14:68-74.
24. Lees C.W., Barrett J.C., Parkes M., Satsangi J. New IBD genetics: common pathways with other diseases. Gut 2011, 60:1739-1753.
25. Martinez-Medina M., Aldeguer X., Gonzalez-Huix F., Acero D., Garcia-Gil L.J. Abnormal microbiota composition in the ileocolonic mucosa of Crohn's disease patients as revealed by polymerase chain reaction-denaturing gradient gel electrophoresis. Inflamm. Bowel Dis. 2006, 12:1136-1145.
26. Miao E.A., Leaf I.A., Treuting P.M., Mao D.P., Dors M., Sarkar A., Warren S.E., Wewers M.D., Aderem A. Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria. Nat. Immunol. 2010, 11:1136-U1194.
27. Mondot S., Kang S., Furet J.P., de Carcer D.A., McSweeney C., Morrison M., Marteau P., Dore J., Leclerc M. Highlighting new phylogenetic specificities of Crohn's disease microbiota. Inflamm. Bowel Dis. 2011, 17:185-192.
28. Munkholm P., Langholz E., Nielsen O.H., Kreiner S., Binder V. Incidence and prevalence of Crohn's-disease in the county of Copenhagen, 1962-87 - a sixfold increase in incidence. Scand. J. Gastroenterol. 1992, 27:609-614.
29. Nakanishi K., Yoshimoto T., Tsutsui H., Okamura H. Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev. 2001, 12:53-72.
30. Olesen B., Neimann J., Bottiger B., Ethelberg S., Schiellerup P., Jensen C., Helms M., Scheutz F., Olsen K.E.P., Krogfelt K., Petersen E., Molbak K., Gerner-Smidt P. Etiology of diarrhea in young children in Denmark: a case-control study. J. Clin. Microbiol. 2005, 43:3636-3641.
31. Petersen A.M., Nielsen E.M., Litrup E., Brynskov J., Mirsepasi H., Krogfelt K.A. A phylogenetic group of Escherichia coli associated with active left-sided Inflammatory Bowel Disease. BMC Microbiol. 2009, 9:171.
32. Picard B., Garcia J.S., Gouriou S., Duriez P., Brahimi N., Bingen E., Elion J., Denamur E. The link between phylogeny and virulence in Escherichia coli extraintestinal infection. Infect. Immun. 1999, 67:546-553.
33. Pizarro T.T., Michie M.H., Bentz M., Woraratanadharm J., Smith M.F., Foley E., Moskaluk C.A., Bickston S.J., Cominelli F. IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: expression and localization in intestinal mucosal cells. J. Immunol. 1999, 162:6829-6835.
34. Rallabhandi P., Awomoyi A., Thomas K.E., Phalipon A., Fujimoto Y., Fukase K., Kusumoto S., Qureshi N., Sztein M.B., Vogel S.N. Differential activation of human TLR4 by Escherichia coli and Shigella flexneri 2a lipopolysaccharide: combined effects of lipid A acylation state and TLR4 polymorphisms on signaling. J. Immunol. 2008, 180:1139-1147.
35. Roses R.E., Xu S.W., Xu M., Koldovsky U., Koski G., Czerniecki B.J. Differential production of IL-23 and IL-12 by myeloid-derived dendritic cells in response to TLR agonists. J. Immunol. 2008, 181:5120-5127.
36. Sakuraba A., Sato T., Kamada N., Kitazume M., Sugita A., Hibi T. Th1/Th17 immune response is induced by mesenteric lymph node dendritic cells in Crohn's disease. Gastroenterology 2009, 137:1736-1745.
37. Sivakumar P.V., Westrich G.M., Kanaly S., Garka K., Born T.L., Derry J.M.J., Viney J.L. Interleukin 18 is a primary mediator of the inflammation associated with dextran sulphate sodium induced colitis: blocking interleukin 18 attenuates intestinal damage. Gut 2002, 50:812-820.
38. Sokol H., Lepage P., Seksik P., Dore J., Marteau P. Temperature gradient gel electrophoresis of fecal 16S rRNA reveals active Escherichia coli in the microbiota of patients with ulcerative colitis. J. Clin. Microbiol. 2006, 44:3172-3177.
39. Sondergaard J.N., Brix S. Isolation of IL-12p70-competent human monocyte-derived dendritic cells. J. Immunol. Methods 2012, 386:112-116.
40. Soong G., Chun J., Parker D., Prince A. Staphylococcus aureus activation of caspase 1/calpain signaling mediates invasion through human keratinocytes. J. Infect. Dis. 2012, 205:1571-1579.
41. Vejborg R.M., Hancock V., Petersen A.M., Krogfelt K.A., Klemm P. Comparative genomics of Escherichia coli isolated from patients with inflammatory bowel disease. BMC Genomics 2011, 12:316-328.